Literature DB >> 20141680

NCCN clinical practice guidelines in oncology: prostate cancer early detection.

Mark H Kawachi, Robert R Bahnson, Michael Barry, J Erik Busby, Peter R Carroll, H Ballentine Carter, William J Catalona, Michael S Cookson, Jonathan I Epstein, Ruth B Etzioni, Veda N Giri, George P Hemstreet, Richard J Howe, Paul H Lange, Hans Lilja, Kevin R Loughlin, James Mohler, Judd Moul, Robert B Nadler, Stephen G Patterson, Joseph C Presti, Antoinette M Stroup, Robert Wake, John T Wei.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20141680     DOI： 10.6004/jnccn.2010.0016

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  65 in total

1.  Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.

Authors:  Allen S Ho; Lu Wang; Frank L Palmer; Changhong Yu; Arnbjorn Toset; Snehal Patel; Michael W Kattan; R Michael Tuttle; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2014-11-04       Impact factor: 5.344

2.  Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Authors:  Sigrid Carlsson; Andrew J Vickers; Monique Roobol; James Eastham; Peter Scardino; Hans Lilja; Jonas Hugosson
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

Review 3.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

4.  Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.

Authors:  Michael S Borofsky; Danil V Makarov
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

5.  Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study.

Authors:  Hao Zi; Lei Gao; Zhaohua Yu; Chaoyang Wang; Xuequn Ren; Jun Lyu; Xiaodong Li
Journal:  Int Urol Nephrol       Date:  2019-10-14       Impact factor: 2.370

6.  Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.

Authors:  Yaw A Nyame; Adam B Murphy; Diana K Bowen; Gregory Jordan; Ken Batai; Michael Dixon; Courtney M P Hollowell; Stephanie Kielb; Joshua J Meeks; Peter H Gann; Virgilia Macias; Andre Kajdacsy-Balla; William J Catalona; Rick Kittles
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

7.  Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening.

Authors:  Michael S Borofsky; Danil V Makarov
Journal:  Asian J Androl       Date:  2011-05-02       Impact factor: 3.285

8.  Prostate cancer: treatment triggers for patients on active surveillance.

Authors:  William M Hilton; Dipen J Parekh
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

9.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

Review 10.  Risk stratification in prostate cancer screening.

Authors:  Monique J Roobol; Sigrid V Carlsson
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.